- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
House lawmakers late Wednesday evening (March 9) passed by a vote of 260--171 a bipartisan, bicameral omnibus spending bill that gives FDA $3.3 billion in discretionary funding for fiscal 2022, a $102 million increase over fiscal 2021 levels but still less than what House and Senate appropriators proposed for the agency last year during their first attempt at passing fiscal 2022 funding legislation.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us